Avidity Biosciences, Inc (RNAM) — Cash Flow Reinvestment Rate
Avidity Biosciences, Inc (RNAM) has a Cash Flow Reinvestment Rate of 0.05x as of December 2023, reinvesting $863.00K (capex $863.00K ) from operating cash flow of $16.50 Million. Explore cash efficiency ratio of Avidity Biosciences, Inc to assess how effectively this company generates cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Avidity Biosciences, Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Avidity Biosciences, Inc across 1 annual periods. Explore Avidity Biosciences, Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Avidity Biosciences, Inc (2019–2019)
Year-by-year capital reinvestment analysis for Avidity Biosciences, Inc. For live market cap and broader valuation context, see Avidity Biosciences, Inc (RNAM) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.09x | $235.00K | $2.49 Million | $235.00K | — |